Clinica Baviera (CBAV) Q4 2025 earnings summary

Executive summary

• Revenue increased by 12% year-over-year, with net profit up 15% and growth in all operating countries.

• Eleven new clinics opened, strengthening market position and expanding the patient base.

• Net financial position rose 39% to €42 million, despite significant investments and a €25 million dividend payout.

• Share price appreciated by 59% during the year.

• Operational improvements and digital tools enhanced quality and efficiency metrics.

Financial highlights

• Consolidated revenue reached €301.8 million, up from €270.0 million (+12%).

• EBITDA grew 12% to €84.5 million; net profit rose 15% to €42.9 million.

• Operating expenses increased 17% to €217.2 million.

• Net financial position improved to €42.4 million (+39%).

• Earnings per share increased to €2.58 (+12%).

Outlook and guidance

• Optimism for 2026, the 35th anniversary, driven by operational improvements and AI adoption.

• Continued focus on digital transformation and quality enhancements.